Private Equity
Scientist.com’s sector focuses on pharmaceutical R&D services, biotechnology, life science tools, and contract research.
1 min read · 16 September 2025
'The fundamentals of the industry are driven by demographics, and broadening the scope provides a bit of growth opportunity,' says Kensington's Tom Kennedy.
3 min read · 16 September 2025
Currently, Med First has 27 clinics.
1 min read · 16 September 2025
There's a 'great need' for RCM providers focused on post-acute healthcare services, Sheridan's Jonathan Lewis told PE Hub.
3 min read · 16 September 2025
Fatro is a company in the veterinary pharmaceutical sector.
1 min read · 16 September 2025
An increasing number of patients are seeking care in outpatient settings such as ambulatory surgery centers over hospitals due to their affordability and shorter wait times. A round-up of these deals from the last six months. Also: a look at a dual acquisition by Accord Asset Partners and Paras Capital Partners in a physical therapy provider network.
3 min read · 12 September 2025
The capital infusion will be used by FCS for continued expansion.
1 min read · 12 September 2025
Great Hill Partners, Olympus Partners and Wellspring Capital Management are among the PE firms investing in ambulatory surgical care.
2 min read · 12 September 2025
Vitruvian will acquire a majority stake in DeepIntent following this transaction.
1 min read · 11 September 2025
In addition to this transaction, BowRiver has merged meQ with portfolio company, RippleWorx, a Huntsville, Alabama-based talent development software firm.
1 min read · 11 September 2025